The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Neogenomics Inc. (NEO) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.81, or -4.15%, to $18.70. The Neogenomics Inc. has recorded 11,806 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference.
The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $19.51 and fluctuated between $19.57 as its day high and $19.05 as its day low. The current market capitalization of Neogenomics Inc. is $2.49B. A total of 0.82 million shares were traded on the day, compared to an average of 930.89K shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, NEO has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 1,680 shares. Over the last 12 months, there were 6 BUYs and 9 SELLs from insiders. Insiders purchased 332,972 shares during that period but sold 29,477.
In the most recent transaction, Olivo Alicia C sold 2,669 shares of NEO for 18.39 per share on Nov 17. After the transaction, the General Counsel now owns 37,140 company shares.
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. NEO’s most recent ex-dividend date was 12/17/2020 when it declared a $0.40 quarterly dividend that was paid in cash on 12/30/2020.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for NEO in the last 3 months, the mean price target is $21.00 with high estimates of $30.00 and low estimates of $16.00. In terms of 52-week highs and lows, NEO has a high of $20.54 and a low of $8.70.
As of this writing, NEO has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $0 per share and a lower estimate of -$0.12. The company reported an EPS of -$0.05 in the last quarter, which was 54.50% higher than expectations of -$0.11.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NEO’s latest balance sheet shows that the firm has $515.39M in Cash & Short Term Investments as of fiscal 2021. There were $612.79M in debt and $87.23M in liabilities at the time. Its Book Value Per Share was $7.44, while its Total Shareholder’s Equity was $1.11B.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NEO is Buy with a score of 4.42.